Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue.
Pál TodAnita VargaViktor RománBalázs LendvaiRoland PálkovácsBeáta SperlághE Sylvester ViziPublished in: British journal of pharmacology (2024)
Our observations provide neurochemical evidence explaining the mechanism of VMAT-2 inhibitors in the brain and support the involvement of dopaminergic and noradrenergic transmission in hyperkinetic movement disorders.